Glenmark was established with the goal of becoming a preeminent, fully integrated, international pharmaceutical firm. The company’s branded generics division is well-established in emerging market markets like India.
The generics industry serves the needs of developed markets like the United States and Western Europe. The company’s API division sells its goods in more than 65 nations, including the US, several EU nations, South America, and India.
Glenmark Pharmaceuticals on Wednesday said it has joined hands with Omron Healthcare India to raise awareness on measuring blood pressure at home from the age of 18.
The Mumbai-based drug maker said it initiated discussions with 94 cardiologists across India, leading to a consensus that 18 is the ideal age to commence blood pressure screening.
“There has been a concerning rise in the incidence of hypertension among young adults in India, with about 10-30 per cent of young adults (below 40 years of age) suffering from high blood pressure in the country,” Glenmark Pharmaceuticals Executive Vice President & Head of India Formulations Alok Malik said in a statement.
According to a cross-sectional study conducted by the Indian Council of Medical Research (ICMR) in 2023, the prevalence of hypertension has witnessed a concerning rise, reaching 35.5 per cent for people in the age group of 20-plus compared to 29.8 per cent in 2014.
In urban areas, this prevalence is even higher at 40.7 per cent.
